Clinical Trial Update: Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring neoadjuvant celecoxib in newly diagnosed endometrial carcinoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Endometrium Cancer | Phase 2 | Status: UNKNOWN